Estelle Marrer

1.3k total citations · 1 hit paper
13 papers, 885 citations indexed

About

Estelle Marrer is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Estelle Marrer has authored 13 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Nephrology and 3 papers in Epidemiology. Recurrent topics in Estelle Marrer's work include Advanced Biosensing Techniques and Applications (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and RNA modifications and cancer (2 papers). Estelle Marrer is often cited by papers focused on Advanced Biosensing Techniques and Applications (3 papers), Chronic Kidney Disease and Diabetes (3 papers) and RNA modifications and cancer (2 papers). Estelle Marrer collaborates with scholars based in Switzerland, United States and United Kingdom. Estelle Marrer's co-authors include Frank Dieterle, Jacky Vonderscher, André Cordier, Vishal S. Vaidya, Gerald Maurer, Josef Ozer, Joseph V. Bonventre, Peter L. Goering, Nagaraja Muniappa and Elias Perentes and has published in prestigious journals such as Nature Biotechnology, American Journal of Respiratory and Critical Care Medicine and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Estelle Marrer

13 papers receiving 859 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies

2010 520 citations Vishal S. Vaidya, Josef Ozer et al. Nature Biotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Estelle Marrer Switzerland	11	282	236	96	94	90	13	885
Thierry Le Bricon France	17	543 1.9×	268 1.1×	92 1.0×	52 0.6×	159 1.8×	44	1.3k
Douglas T. Thudium United States	5	356 1.3×	279 1.2×	63 0.7×	64 0.7×	63 0.7×	5	858
Masaya Yamanouchi Japan	10	468 1.7×	342 1.4×	144 1.5×	59 0.6×	38 0.4×	16	1.1k
Nagaraja Muniappa United States	17	381 1.4×	694 2.9×	149 1.6×	62 0.7×	72 0.8×	24	1.7k
Yafei Liu China	18	116 0.4×	295 1.3×	71 0.7×	50 0.5×	82 0.9×	77	884
Barry A. Rosenzweig United States	16	162 0.6×	382 1.6×	40 0.4×	33 0.4×	39 0.4×	28	921
Τushar Garimella United States	17	384 1.4×	198 0.8×	153 1.6×	76 0.8×	180 2.0×	44	1.4k
Ryota Tanaka Japan	16	74 0.3×	295 1.3×	86 0.9×	110 1.2×	88 1.0×	90	850
Guoqiang Zhang China	17	165 0.6×	397 1.7×	186 1.9×	36 0.4×	178 2.0×	92	1.1k
M Ruddel United States	17	163 0.6×	238 1.0×	103 1.1×	34 0.4×	61 0.7×	38	846

Countries citing papers authored by Estelle Marrer

Since Specialization

Citations

This map shows the geographic impact of Estelle Marrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Estelle Marrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Estelle Marrer more than expected).

Fields of papers citing papers by Estelle Marrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Estelle Marrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Estelle Marrer. The network helps show where Estelle Marrer may publish in the future.

Co-authorship network of co-authors of Estelle Marrer

This figure shows the co-authorship network connecting the top 25 collaborators of Estelle Marrer. A scholar is included among the top collaborators of Estelle Marrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Estelle Marrer. Estelle Marrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Vaidya, Vishal S., Josef Ozer, Frank Dieterle, et al.. (2010). Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nature Biotechnology. 28(5). 478–485. 520 indexed citations breakdown →

Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Imatinib does not induce cardiotoxicity at clinically relevant concentrations in preclinical studies. Leukemia Research. 34(9). 1180–1188. 58 indexed citations

Wolf, Armin, Philippe Couttet, Min Dong, et al.. (2010). Preclinical evaluation of potential nilotinib cardiotoxicity. Leukemia Research. 35(5). 631–637. 16 indexed citations

Baty, Florent, Sérgio Kaiser, M. Schumacher, et al.. (2009). Gene Profiling of Clinical Routine Biopsies and Prediction of Survival in Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 181(2). 181–188. 37 indexed citations

Marrer, Estelle & Frank Dieterle. (2009). Impact of biomarker development on drug safety assessment. Toxicology and Applied Pharmacology. 243(2). 167–179. 54 indexed citations

Marrer, Estelle & Frank Dieterle. (2008). Biomarkers in oncology drug development: rescuers or troublemakers?. Expert Opinion on Drug Metabolism & Toxicology. 4(11). 1391–1402. 10 indexed citations

Dieterle, Frank, Estelle Marrer, Eiko Suzuki, et al.. (2008). Monitoring kidney safety in drug development: emerging technologies and their implications.. PubMed. 11(1). 60–71. 29 indexed citations

Dieterle, Frank & Estelle Marrer. (2007). New technologies around biomarkers and their interplay with drug development. Analytical and Bioanalytical Chemistry. 390(1). 141–154. 16 indexed citations

Marrer, Estelle & Frank Dieterle. (2007). Promises of Biomarkers in Drug Development – A Reality Check. Chemical Biology & Drug Design. 69(6). 381–394. 36 indexed citations

10.

Marrer, Estelle, Florent Baty, Jeanne Kehren, Salah‐Dine Chibout, & Martin Brutsche. (2006). Past, Present and Future of Gene Expression-Tailored Therapy for Lung Cancer. Personalized Medicine. 3(2). 165–175. 4 indexed citations

11.

Marrer, Estelle, et al.. (2006). Involvement of the Putative ATP-Dependent Efflux Proteins PatA and PatB in Fluoroquinolone Resistance of a Multidrug-Resistant Mutant of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 50(2). 685–693. 48 indexed citations

12.

Gomez‐Mancilla, Baltazar, Estelle Marrer, Jeanne Kehren, et al.. (2005). Central nervous system drug development: An integrative biomarker approach toward individualized medicine. PubMed. 2(4). 683–695. 17 indexed citations

13.

Marrer, Estelle, et al.. (2005). Global Transcriptome Analysis of the Responses of a Fluoroquinolone-Resistant Streptococcus pneumoniae Mutant and Its Parent to Ciprofloxacin. Antimicrobial Agents and Chemotherapy. 50(1). 269–278. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact